Author

Sami Alexander Safi

Düsseldorf University HospitalORCID 0000-0002-9874-9225Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Irene EspositoiD· 2 shared Wolfram Trudo KnoefeliD· 2 shared Abhimanyu DasGupta· 1 shared Alberto DelaidelliiD· 1 shared Anthony BeucheriD· 1 shared Aslihan YavasiD· 1 shared Bin Yu· 1 shared César Rodríguez-SantanaiD· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Irene EspositoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GALE-dependent glycoproteome remodelling is a determinant of oncogenic RAS transformation

Frauke Stölting, Rita Vesce, César Rodríguez-Santana, Marina Ciscar, Alberto Delaidelli, Qiaochu Lin, Christian Ballmeyer, Sophie Chan, Ramona Lesch, Ruitong Li, Abhimanyu DasGupta, Bin Yu, Daniel Picard, Vithusan Suppiyar, Francesco Casini, , Jonathan K. M. Lim

This study identifies GALE as a key regulator of glycoproteome remodelling in RAS-driven cancer, showing its role in sialylation and tumorigenicity.

bioRxiv · Jun 23, 2026 · PreprintCancer Biology

HNF1A recruits UTX to activate a differentiation program that suppresses pancreatic cancer

Mark Kalisz, Edgar Bernardo, Anthony Beucher, Miguel Angel Maestro, Natalia del Pozo, I.R. Hernández Millán, Lena Häberle, Martin Schlensog, Sami Alexander Safi, Wolfram Trudo Knoefel, Vanessa Grau, Matías G. De Vas, Karl B. Shpargel, Eva Cristina Vaquero, Terry Magnuson, , Jorge P. Ferrer

This study shows HNF1A recruits UTX to activate a differentiation program that suppresses pancreatic cancer by remodeling enhancers and inhibiting oncogenic pathways.

The EMBO Journal · Mar 10, 2020Peer-reviewedGenomics